Active ingredientGatifloxacinCat. No. P-G019-001CAS 112811-59-3Family · Pharmaceutical analytical standards
Gatifloxacin
A fluoroquinolone developed in Japan, patented in 1986 and approved in 1999 for respiratory and urinary infections; it was also developed as eye drops, used for bacterial conjunctivitis. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?Like moxifloxacin it carries a methoxy group at position 8 of the quinolone ring: a small change that strengthens its activity against gram-positive bacteria.
Go to the active ingredient →Active ingredientGatifloxacinCat. No. P-G019-001CAS 112811-59-3
NitrosamineN-Nitroso GatifloxacinCat. No. P-G019-002
Impurity8-Demethoxy-8-fluoro GatifloxacinCat. No. P-G019-003CAS 103460-89-5
ImpurityDes N-Methylpiperazine LevofloxacinCat. No. P-G019-004CAS 86794-33-4
ImpurityDesethylene GatifloxacinCat. No. P-G019-005CAS 172426-87-8
ImpurityDespropylene GatifloxacinCat. No. P-G019-006CAS 172426-86-7
ImpurityGatifloxacin Impurity 1Cat. No. P-G019-007
ImpurityGatifloxacin Impurity 2 HydrochlorideCat. No. P-G019-008
ImpurityGatifloxacin Impurity 3Cat. No. P-G019-009CAS 103460-87-3
ImpurityGatifloxacin Impurity 4Cat. No. P-G019-010
ImpurityGatifloxacin Impurity 5Cat. No. P-G019-011CAS 1497338-46-1
ImpurityGatifloxacin N-OxideCat. No. P-G019-013CAS 1798008-43-1
ImpurityGatifloxacin Related Compound DCat. No. P-G019-014CAS 112811-57-1
ImpurityIso-GatifloxacinCat. No. P-G019-015CAS 1029364-65-5
ImpurityN-Hydroxy GatifloxacinCat. No. P-G019-016CAS 1335198-95-2
ImpurityN-Methyl Gatifloxacin HClCat. No. P-G019-017CAS 114213-77-3
ImpurityO-Desmethyl Gatifloxacin HBrCat. No. P-G019-018No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.